Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001702626-22-000002

Options or other derivatives

  • CEO & President acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Equels Thomas K CEO & President 2022-03-03 Grant or award · Options +50,000 50,000 D: show line 1 in the form
Loading xslF345X03/primary_doc.xml…